Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New cat virus could reveal insights about hepatitis B
Until now, it was not known that companion animals could contract HBV.

Discovery first step in developing vaccine to prevent infection

Scientists in Australia have discovered hepadnavirus (HBV) in an immunocompromised feline.

Until now, it was not known that companion animals could contract HBV - a virus that is in the same family as hepatitis B. Researchers said that the importance of the finding could not be overstated.

“Finding a new virus responsible for disease is the first step in developing a vaccine to prevent infection,” said Dr Kelly Diehl of the Morris Animal Foundation, which funded the research. “It’s especially exciting if the vaccine could prevent a future cancer from developing in immunocompromised or other vulnerable cats.”

The virus was first discovered by a team at the University of Sydney in an immunodeficient cat that had died of lymphoma. After identifying the virus, the researchers tested stored blood samples from adult cats.

To their surprise, they found evidence of hepadnavirus infection in the samples.

“This is a very exciting discovery,” said corresponding author Julia Beatty, Professor of Feline Medicine at Sydney. “Apart from its relevance for feline health, this discovery helps us understand how hepatitis viruses – which can be deadly – are evolving in all species."

The study, published in the journal Viruses, notes that the discovery presents no risk to humans or other pets.

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.